Clinical Trial Update: Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of coadministration of FOV1101-00 with Prednisolone Acetate in patients with mild ocular allergic inflammation (allergic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• FOV1101-00
• Prednisolone acetate (Prednisolone acetate)

Snippet

Sponsor: Fovea Pharmaceuticals SA | Conditions: Allergic Conjunctivitis | Phase 2 | Status: COMPLETED